Multilingual Clinical NER for Diseases and Medications Recognition in Cardiology Texts using BERT Embeddings
Manuela Daniela Danu, George Marica, Constantin Suciu, Lucian Mihai Itu, Oladimeji Farri
TL;DR
This study tackles multilingual clinical NER for diseases and medications in cardiology texts by fine-tuning general-domain BERT models on domain-specific bilingual and trilingual data. It deploys four monolingual and two multilingual models across Spanish, English, and Italian within the BioASQ MultiCardioNER framework, evaluating two subtasks: Spanish diseases recognition and multilingual medications recognition. The results show strong gains in medication recognition across languages, with SDR, SMR, EMR, and IMR achieving high F1 scores and outperforming leaderboard baselines, though disease recognition remains more challenging and exhibits some overfitting in fine-tuned variants. The work highlights the potential of transfer learning from general-domain to biomedical multilingual NER and paves the way for integrating larger language models to further enhance clinical information extraction in cardiology.
Abstract
The rapidly increasing volume of electronic health record (EHR) data underscores a pressing need to unlock biomedical knowledge from unstructured clinical texts to support advancements in data-driven clinical systems, including patient diagnosis, disease progression monitoring, treatment effects assessment, prediction of future clinical events, etc. While contextualized language models have demonstrated impressive performance improvements for named entity recognition (NER) systems in English corpora, there remains a scarcity of research focused on clinical texts in low-resource languages. To bridge this gap, our study aims to develop multiple deep contextual embedding models to enhance clinical NER in the cardiology domain, as part of the BioASQ MultiCardioNER shared task. We explore the effectiveness of different monolingual and multilingual BERT-based models, trained on general domain text, for extracting disease and medication mentions from clinical case reports written in English, Spanish, and Italian. We achieved an F1-score of 77.88% on Spanish Diseases Recognition (SDR), 92.09% on Spanish Medications Recognition (SMR), 91.74% on English Medications Recognition (EMR), and 88.9% on Italian Medications Recognition (IMR). These results outperform the mean and median F1 scores in the test leaderboard across all subtasks, with the mean/median values being: 69.61%/75.66% for SDR, 81.22%/90.18% for SMR, 89.2%/88.96% for EMR, and 82.8%/87.76% for IMR.
